Access to quality vaccines, medicines, and health technologies in Rwanda
KWIGIRA
Rwanda
Access to quality vaccines, medicines, and health technologies in Rwanda
Global Gateway: MSc and PhD programmes in Biotechnology launched in partnership between Team Europe and University of Rwanda
EU-Enabel contribution to Rwanda’s Health workforce through Master and PhD programmes in Biotechnology
Preparedness workshop to implement MSc Programme in Biotechnology
| Résumé projet | |
|
The KWIGIRA project, Access to quality vaccines, medicines, and health technologies in Rwanda aims to strengthen entrepreneurship and to improve the business environment and attractiveness of Rwanda for pharmaceutical investments in order to ensure access to quality vaccines, medicines, and health technologies in Africa. |
|
| Code | RWA21001 |
| Date de début | 18 April 2022 |
| Date de fin | 18 April 2026 |
| Phase | Execution |
| Bailleur | European Union |
| Secteur | 25010 Business support services and institutions |
| Budget | 7 042 056.00 € |
Objectif général
The business environment and attractiveness of Rwanda for pharmaceutical investments is enhanced to ensure access to quality vaccines, medicines, and health technologies in Africa
Objectifs spécifiques
A - To assist Rwanda FDA to adequately perform its mission to protect public health and to reach and maintain maturity level 3 of WHO Global Benchmarking Tool (GBT) to fully regulate pharmaceutical products including vaccines manufacturing in Rwanda.
Actualités
Pas d'actualité